Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 0.93 AUD 0.54% Market Closed
Market Cap: 188.7m AUD
Have any thoughts about
Imricor Medical Systems Inc?
Write Note

Imricor Medical Systems Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imricor Medical Systems Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Imricor Medical Systems Inc
ASX:IMR
Operating Expenses
-$15.7m
CAGR 3-Years
-11%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Expenses
-$6.3B
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Operating Expenses
-$8.1B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Operating Expenses
-$9.2B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Operating Expenses
-$16B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Expenses
-$3.2B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
No Stocks Found

Imricor Medical Systems Inc
Glance View

Market Cap
188.7m AUD
Industry
Health Care

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

IMR Intrinsic Value
0.46 AUD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Imricor Medical Systems Inc's Operating Expenses?
Operating Expenses
-15.7m USD

Based on the financial report for Dec 31, 2023, Imricor Medical Systems Inc's Operating Expenses amounts to -15.7m USD.

What is Imricor Medical Systems Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-22%

Over the last year, the Operating Expenses growth was 0%. The average annual Operating Expenses growth rates for Imricor Medical Systems Inc have been -11% over the past three years , -22% over the past five years .

Back to Top